Skip to content

A study on combined effect of Shatavaryadi Churna along with Phalatrikadi Ghrita Tarpana in treating Simple Myopia.

A RANDOMISED CONTROLLED CLINICAL TRIAL TO STUDY THE ADJUVANT EFFECT OF SHATAVARYADI CHURNA ALONG WITH PHALATRIKADI GHRITA TARPANA IN PRATHAM PATALGATA TIMIRA WITH SPECIAL REFERENCE TO SIMPLE MYOPIA. - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2026/01/102306
Enrollment
50
Registered
2026-01-28
Start date
Unknown
Completion date
Unknown
Last updated
2026-02-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: H521- Myopia

Interventions

None listed

Sponsors

Dr Shreya Babaso Kamble
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1)Patient with symptoms of Pratham Patalagata Timira like Indistinct distant vision, Eye strain, headache. 2) Patient aged 18 to 30 yrs 3)Patient who have less than -3D refractive index in the eyes with normal ophthalmic findings.

Exclusion criteria

Exclusion criteria: 1) Patient who have symptoms of Dwitiya,Tritiya and Chaturtha Patalagata Timira will be Excluded. 2) Congenital myopia, pathological myopia and acquired or secondary myopia resulting from factors or conditions such as trauma, drug use or post-keratitis will be excluded. 3) Patient who have myopia associated with other refractive errors such as Astigmatism or other ocular diseases like cataract, glaucoma, retinal diseases etc. will be excluded. 4) Patients with a known history of DM, hypertension, rheumatic heart disease, thyroid disorders, asthma, tuberculosis (Koch s), HIV or with active infectious diseases like viral, fungal, or bacterial conjunctivitis, trachoma or blepharitis.

Design outcomes

Primary

MeasureTime frame
To study the adjuvant effect of Shatavaryadi Churna along with Phalatrikadi ghrita Tarpana in signs and symptoms of Pratham Patalgata Timira with the help of assessment criteria.Timepoint: 21 days

Secondary

MeasureTime frame
Where the trial group stands in comparison with control group in reduction of signs and symptoms of Pratham Patalgata Timira.Timepoint: 18 months

Countries

India

Contacts

Public ContactDr Shreya Babaso Kamble

SMBT Ayurved College and Hospital,Dhamangaon,Igatpuri,Nashik 422403

petalsayu@gmail.com9850447661

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 7, 2026